revis estim base covid
summari close today issu updat
impact busi gener updat
provid in-lin weve seen med-tech
compani report result color trend
earli base mdt comment estim
account lower normal end
quarter stock addit mdt comment impli sale
year-over-year basi sinc mid-march compani
also note expect signific de-lever
earn significantli sale import note
mdt end april includ addit
month impact compar compani report
calendar year basi light updat
updat model reflect best estim impact
compani
financi assum vast major
procedur postpon month
april may june experi revenu headwind
august septemb albeit less sever number assum
catch sale calendar lost sale
recoup calendar lower
revenu forecast
organ y/i growth reduc sale estim
organ y/i growth
decreas ep estim
lower price target
ep
impact segment gener in-lin expect
follow tabl list busi therapi might
consid urgent moder elect elect
current pandem would expect elect
segment impact
continu follow page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort reflect combin follow
acquisit cov
compani data secur llc estim reuter
continu previou page
figur mdt segment level urgenc
cardiac
respiratori patient
see similar impact busi experienc medic devic compani
provid insight impact busi major geographi highlight
declin similar magnitud discuss medic devic compani month
februari china asia pacif march western europ unit state calendar
china repres approxim total compani revenu compani
expect experi impact revenu entir fiscal fourth quarter
averag weekli revenu declin approxim year-over-year week march sinc
time compani weekli revenu declin averag approxim year-over-
year market experienc slow recoveri
western europ repres approxim total compani revenu
compani began see impact revenu week march last
week compani weekli revenu declin approxim year-over-year
averag exclud impact custom bulk purchas
unit state repres approxim total compani revenu
compani began see impact revenu week march last
week compani weekli revenu declin approxim year-over-year averag
exclud impact custom bulk purchas
rest world repres remain percent total compani revenu
saw vari degre impact last week declin averag approxim
year-over-year
addit impact revenu procedur volum declin compani expect
increment neg impact revenu declin typic larg end fiscal year custom
order custom priorit preserv cash reduc hold purchas product
inventori especi elect procedur categori well purchas certain capit
see potenti offset neg impact vast
major mdt busi experienc declin result compani certain
product line high demand result
cardiac vascular group extracorpor life support product includ ecmo machin
dispos within cardiac surgeri busi
minim invas therapi group ventil puls oximetri capnographi advanc
paramet monitor product within respiratori patient monitor busi
diabet group suppli consum
togeth product line repres approxim global
revenu import note sale declin region discuss includ
expect signific de-lever regard expens expect signific de-lever
earn declin significantli revenu fiscal fourth quarter gener compani
continu invest employe includ sale forc despit decreas
revenu addit compani run mani factori near full capac
provid inventori support anticip rebound procedur expect recoveri period
significantli reduc employe travel major benefit
recogn fiscal first quarter final compani expect neg mix shift gross
margin product higher demand ventil diabet suppli gener carri
strong balanc sheet current billion cash invest
recent quarter undrawn billion credit facil compani public debt matur
march continu focu make capit alloc decis drive long-term
strategi includ invest employe pipelin well activ look tuck-in
acquisit opportun pay strong dividend sharehold
believ see earli sign recoveri indic releas
start enter earli stage global recoveri hospit begin resum broader treatment
patient around world expect busi begin recov well
price target
price target base cash ep estim risk
includ weak key end market greater share loss model delay product
believ acceler growth stori trade discount peer organ growth
acceler come quarter due new product launch micra av surgic
robot linq diabet pump next gener interstim renal denerv
found minneapolis-bas lead global medic technolog compani
focus provid therapi chronic diseas compani four primari busi cardiac
vascular restor therapi minim invas therapi diabet revenu
